Related Experiment Video
Updated: Aug 11, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Smoking cessation and depression: current knowledge and future directions
Kay Wilhelm1, Lucinda Wedgwood, Heather Niven
1School of Psychiatry, University of NSW and Mood Disorders Unit, Black Dog Institute, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Abstract:
This paper reviews the literature on comorbid smoking and depression. Current models used to explain this co-occurrence are examined, as are treatment options (both psychological and pharmacological). This paper surmises that treatment planning should consider factors that potentially confound treatment efficacy, including the nature of the depressive illness and the patient's smoking profile. Although there is limited research examining the benefits of a stepped-care framework, a tiered treatment format appears to work well, assisting those who require minimal treatment, as well as those who prolonged difficulties. Further research examining a stepped-care framework for smokers at risk of depression is required, as is appropriate training for health practitioners using this model. Further directions for research and practice are also discussed.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: Overview